Senior insider sale
Chief Scientific Officer at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$21.47M
984.80K shares
ROBINS HARLAN S plans to sell 984.80K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $21.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Acquired as compensation -- Performance Awards Compensation | 207.60K | — |
2/7/2018 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 284.80K | — |
| Total | 492.40K | ||
Completed
Units to sell
250K
Market value
$5.57M
Units to sell
136.24K
Market value
$2.94M
Units to sell
6.16K
Market value
$110.9K
Units to sell
100K
Market value
$1.74M
Planned — Approximate Date
Units to sell
492.40K
Market value
$11.12M
Units
984.80K
Value
$21.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/2/2026 | 250K | $5.57M | — | Completed |
7/2/2026 | 136.24K | $2.94M | — | Completed |
6/16/2026 | 6.16K | $110.9K | — | Completed |
6/15/2026 | 100K | $1.74M | — | Completed |
| Planned — Approximate Date | ||||
7/21/2026 | 492.40K | $11.12M | NASD | Planned |
| Total | 984.80K | $21.47M | ||